/ANPC
ANPC Stock - AnPac Bio-Medical Science Co., Ltd.
Healthcare|BiotechnologyNASDAQ
$4.30-3.15%
$0.14 (-3.15%) • May 19
48
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.8
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.58
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $4.73
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ANPC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$4.26 – $4.34
TARGET (TP)$4.94
STOP LOSS$3.96
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.56
52W High$11.99
52W Low$2.60
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $12.04M | $17.99M | $20.51M | $10.85M | $10.25M |
| Gross Profit | $8.34M | $12.25M | $12.88M | $4.80M | $4.58M |
| Gross Margin | 69.2% | 68.1% | 62.8% | 44.2% | 44.7% |
| Operating Income | $-84,138,000 | $-106,046,000 | $-93,126,000 | $-89,082,000 | $-43,609,000 |
| Net Income | $-103,598,000 | $-120,087,000 | $-80,565,000 | $-101,621,000 | $-42,063,000 |
| Net Margin | -860.2% | -667.7% | -392.8% | -937.0% | -410.4% |
| EPS | $-54.18 | $-176.53 | $-143.99 | $-205.96 | $-3.76 |
Company Overview
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ANPCBeat Rate
0%
Last 1 quarters
Avg Surprise
-26.8%
EPS vs Estimate
Beats / Misses
0/1
Last 12 quarters
Latest EPS
$-2.47
Q1 2023
EPS Surprise History
Q2 21
No data
Q4 21
No data
Q4 21
No data
Q2 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2023 | May 16, 2023 | — | — | — | — |
Q1 2023 | Jan 9, 2023 | — | $-2.47 | — | — |
Q4 2022 | Dec 19, 2022 | — | $-0.16 | — | — |
Q3 2022 | Sep 29, 2022 | — | $-5.85 | — | — |
Q2 2022 | Jun 20, 2022 | — | $-2.71 | — | — |
Q2 2022 | May 31, 2022 | — | $-2.00 | — | — |
Q4 2021 | Nov 26, 2021 | — | $-0.40 | — | — |
Q4 2021 | Oct 12, 2021 | — | $-7.24 | — | — |
Q2 2021 | May 27, 2021 | — | $-7.39 | — | — |
Q2 2021 | Apr 30, 2021 | $-2.20 | $-2.79 | -26.8% | ✗ MISS |
Q3 2020 | Sep 30, 2020 | — | $-3.33 | — | — |
Q3 2020 | Sep 10, 2020 | — | $-3.23 | — | — |
Q2 2020 | May 18, 2020 | — | $-5.51 | — | — |
Q2 2020 | May 15, 2020 | — | $-8.77 | — | — |
Q1 2020 | Jan 31, 2020 | — | $-8.81 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.13 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ANPC
What is ANPC's current stock price?
AnPac Bio-Medical Science Co., Ltd. (ANPC) is currently trading at $4.30 per share. The stock has moved -3.15% today.
What is the analyst price target for ANPC?
No analyst price targets are currently available for this stock.
What sector is AnPac Bio-Medical Science Co., Ltd. in?
AnPac Bio-Medical Science Co., Ltd. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is ANPC's market cap?
AnPac Bio-Medical Science Co., Ltd. has a market capitalization of $0.03 billion, making it a small-cap company.
Does ANPC pay dividends?
No, AnPac Bio-Medical Science Co., Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALLK
Allakos Inc.
$0.33
Mkt Cap: $0.0B
ANGN
Angion Biomedica Corp.
$1.00
Mkt Cap: $0.0B
ELEV
Elevation Oncology, Inc.
$0.36
Mkt Cap: $0.0B
FRLN
Freeline Therapeutics Holdings plc
$6.49
Mkt Cap: $0.0B
GMTX
Gemini Therapeutics, Inc.
$1.35
Mkt Cap: $0.0B
LMNL
Liminal BioSciences Inc.
$8.50
Mkt Cap: $0.0B
LSB
LakeShore Biopharma Co., Ltd
$0.63
Mkt Cap: $0.0B
MRNS
Marinus Pharmaceuticals, Inc.
$0.55
Mkt Cap: $0.0B
SER
Serina Therapeutics, Inc.
$2.75
Mkt Cap: $0.0B
VINC
Vincerx Pharma, Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to ANPC for comparison